RNS Number : 8490X Renalytix PLC 10 January 2022     Renalytix plc ("Renalytix" or the "Company")   Singing River Health System and Renalytix Join Forces to Improve Kidney Health   on the   Mississippi Gulf Coast Seventh KidneyIntelX implementation partnership for Renalytix focused on underserved

NEW YORK and SALT LAKE CITY, Jan. 07, 2022 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced that Jean M. Casner joined the Company this week on January 3, 2022 as Senior Vice President & Chief Human Resources Officer. Ms. Casner will be responsible for Renalytix’s global

RNS Number : 7098X Renalytix PLC 07 January 2022     Renalytix plc ("Renalytix" or the "Company")   Renalytix Appoints Jean M. Casner as Chief Human Resources Officer   NEW YORK, NY and SALT LAKE CITY, UT   January 7, 2022 - Renalytix plc   (NASDAQ: RNLX) (LSE: RENX) today announced that Jean M.

NEW YORK and SALT LAKE CITY, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Renalytix plc (LSE: RENX) (NASDAQ: RNLX) (“Renalytix” or the “Company”) today announced the Company will be presenting at the upcoming 40 th Annual J.P. Morgan Virtual Healthcare Conference.

RNS Number : 4318X Renalytix PLC 05 January 2022     Renalytix plc ("Renalytix" or the "Company")   Renalytix to Present at 40 th Annual J.P. Morgan Virtual Healthcare Conference   LONDON and SALT LAKE CITY , January 5, 2022 - Renalytix plc (LSE: RENX) (NASDAQ: RNLX) today announced the Company

National program establishes early care management, technology innovation and large health system engagement as a strategic priority for supporting the 34 million U.S. individuals living with diabetes ARLINGTON, Va. and SALT LAKE CITY, Jan. 04, 2022 (GLOBE NEWSWIRE) -- The American Diabetes

RNS Number : 2538X Renalytix PLC 04 January 2022   Renalytix plc ("Renalytix" or the "Company")   American Diabetes Association and Renalytix Partner to Prioritize Kidney Health in Type 2 Diabetes Population   National program establishes early care management, technology innovation and large

RNS Number : 0925W Renalytix PLC 17 December 2021   Renalytix plc (" Renalytix " or the " Company ")     Result of AGM   LONDON and SALT LAKE , 17 December 2021   - Renalytix (NASDAQ: RNLX)  (LSE: RENX) announces that at the Annual General Meeting ("AGM") held earlier today, all resolutions were

RNS Number : 0593W Renalytix PLC 17 December 2021   Renalytix plc (" Renalytix " or the " Company ")     Director/PDMR Dealing   New York , 17 December 2021 - Renalytix (LSE: RENX) announces that it has been advised of the purchase by Ann Berman , the Company's Non-Executive Director, of 3,000

RNS Number : 3617V Renalytix PLC 13 December 2021   Renalytix plc (" Renalytix " or the " Company ")     Director/PDMR Dealing   New York , 13 December 2021 - Renalytix (LSE: RENX) announces that it has been advised of the purchase by James McCullough , the Company's Chief Executive Officer, of